Search Orphan Drug Designations and Approvals
-
Generic Name: | Novel Acting Thrombolytic (NAT) |
---|---|
Date Designated: | 01/26/2001 |
Orphan Designation: | Treatment of peripheral arterial occlusion (PAO) |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Nuvelo, Inc. Inc. 201 Industrial Road Suite 310 San Carlos, California 94070 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-